← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Dignity Health
San Francisco, CA
$23,012,678
Total funding
20
Grants
Funding over time
peak $9.9M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$22,774,678 · 19
CDC$238,000 · 1
By mechanism
—$22,774,678 · 19
H75$238,000 · 1
Investigators at Dignity Health
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
PATHOGENESIS OF VASCULAR MALFORMATIONS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: FROM DISEASE MECHANISM TO NEW THERAPIES$9,933,291
· FY2017 · Defense Health Agency
PLASTICITY AND NEUROCIRCUIT REMODELING IN THE MEDIOBASAL HYPOTHALAMUS TO TREAT DIABETES$1,739,853
· FY2020 · Defense Health Agency
MRI BIOMARKERS OF TRAUMATIC PERIPHERAL NERVE INJURY AND REPAIR: VALIDATION AND MULTISITE APPLICATION$1,628,512
· FY2022 · Defense Health Agency
A MULTICENTER, RANDOMIZED CONTROLLED TRIAL OF CEREBROSPINAL FLUID DRAINAGE IN ACUTE SPINAL CORD INJURY$1,304,711
· FY2014 · Department of the Army
GENOTYPIC AND PHENOTYPIC EXAMINATION OF DISEASE PATHOGENEIS IN C8ORF72 FTD$1,149,505
· FY2019 · Department of the Army
TARGETING CNS EXPRESSION OF CHITINASES AS A NOVEL THERAPY FOR ALS$881,302
· FY2021 · Defense Health Agency
RETINOID-ACTIVATING GENE THERAPY FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS$782,284
· FY2025 · Defense Health Agency
THE ROLE OF TDP-43 ASSOCIATED CRYPTIC EXON INCLUSION IN KARLN ON C9ORF72-MEDIATED CORTICAL NEURODEGENERATION$722,545
· FY2025 · Defense Health Agency
LONGITUDINAL NEUROIMAGING AND MOLECULAR BIOMARKERS OF CEREBROVASCULAR HEALTH IN ALS$707,134
· FY2025 · Defense Health Agency
ENHANCING ACMSD ACTIVITY AS A NOVEL GENE THERAPY FOR ALS$680,458
· FY2025 · Defense Health Agency
TARGETING SYNAPSE LOSS IN ALS/FTD USING SPINE-REGENERATING COMPOUNDS$664,780
· FY2021 · Defense Health Agency
PATHOGEN-INSPIRED NANOPARTICLE DRUG DELIVERY TO MOTOR NEURONS$600,132
· FY2014 · Department of Defense
A MINIATURIZED VALVE THAT MIMICS FUNCTIONAL ARACHNOID GRANULATIONS TO TREAT HYDROCEPHALUS$506,715
· FY2020 · Defense Health Agency
RIC THERAPY-MEDIATED NEUROPROTECTION IN EYE TRAUMA$389,476
· FY2022 · Defense Health Agency
COGNITIVE AND NEURAL CORRELATES OF AGING IN AUTISM SPECTRUM DISORDER$328,127
· FY2015 · Department of Defense
A NEW, QUANTITATIVE EEG TECHNIQUE FOR PREDICTION OF POST-TRAUMATIC EPILEPSY IN INDIVIDUAL SUBJECTS AFTER TRAUMATIC BRAIN INJURY$300,000
· FY2011 · Department of Defense
THE "WOMEN'S GET HEALTHY STAY HEALTHY" PROJECT WILL ADDRESS THE CAUSES OF PREMATU$238,000
H75 · FY2009 · DP
SINGLE-CELL RNA-SEQ AND CLONAL ANALYSIS OF B CELLS IN MS$236,250
· FY2021 · Defense Health Agency
AXONAL TRANSPORT IN THE NF1 MOUSE MODEL IN VIVO$121,228
· FY2009 · Department of the Army
INVESTIGATING COOPERATION BETWEEN KEAP1 AND LKB1 INACTIVATION IN LUNG ADENOCARCINOMA$98,375
· FY2016 · Department of Defense